KMID : 0613820220320050375
|
|
Journal of Life Science 2022 Volume.32 No. 5 p.375 ~ p.390
|
|
Antiviral Activity of Plant-derived Natural Products against Influenza Viruses
|
|
Kim Seon-Jeong
Kim Ye-Won Kim Ju-Won Hwang Yu-Bin Kim Seong-Hyeon Jang Yo-Han
|
|
Abstract
|
|
|
Influenza viruses are zoonotic respiratory pathogens, and influenza infections have caused a substantial burden on public health systems and the livestock industry. Although currently approved seasonal influenza vaccines have shown potent protection efficacy against antigenically well-matched strains, there are considerable unmet needs for the efficient control of viral infections. Enormous efforts have been made to develop broadly protective universal influenza vaccines to tackle the huge levels of genetic diversity and variability of influenza viruses. In addition, antiviral drugs have been considered important interventions for the treatment of viral infections. The viral neuraminidase inhibitor oseltamivir is the most widely used antiviral medication to treat influenza A and influenza B viruses. However, unsatisfactory clinical outcomes resulting from side effects and the emergence of resistant variants have led to greater attention being paid to plants as a natural resource for anti-influenza drugs. In particular, the recent COVID-19 pandemic has underpinned the need for safe and effective antiviral drugs with a broad spectrum of antiviral activity to prevent the rapid spread of viruses among humans. This review outlines the results of the antiviral activities of various natural products isolated from plants against influenza viruses. Special focus is paid to the virucidal effects and the immune-enhancing effects of antiviral natural products, since the products have broad applications as inactivating agents for the preparation of inactivated vaccines and vaccine adjuvants.
|
|
KEYWORD
|
|
Antiviral drug, influenza virus, natural product, virucidal effect
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|